• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素样生长因子-I(IGF-I)和胰岛素样生长因子结合蛋白3(IGF-BP3)对诊断身材矮小儿童的生长激素缺乏症有用吗?

Are IGF-I and IGF-BP3 useful for diagnosing growth hormone deficiency in children of short stature?

作者信息

Galluzzi Fiorella, Quaranta Maria Rita, Salti Roberto, Saieva Calogero, Nanni Laura, Seminara Salvatore

机构信息

Paediatric Endocrinology Unit, Department of Paediatrics, University of Florence, Azienda Ospedaliero-Universitaria Meyer, Florence, Italy.

出版信息

J Pediatr Endocrinol Metab. 2010 Dec;23(12):1273-9. doi: 10.1515/jpem.2010.201.

DOI:10.1515/jpem.2010.201
PMID:21714461
Abstract

BACKGROUND

The diagnosis of growth hormone deficiency (GHD) is based on clinical and auxological characteristics combined with the results of growth hormone provocation tests.

AIM

To evaluate the utility of IGF-I and IGF-BP3 serum levels in the diagnosis of GHD among children of short stature.

SUBJECTS/METHODS: We recruited 207 short pre-pubertal children and divided them into two groups. One group consisted of 70 children (mean age 7.93 +/- 2.35 SD) with a growth hormone (GH) response on two provocative tests of < or = 8 ng/ml, while the other group contained 137 children (mean age 7.92 +/- 2.11 SD) with a peak GH value of > 8 ng/ml. Serum IGF-1 and IGF-BP3 levels were determined in the two groups.

RESULTS

The difference in serum IGF-I between the two groups was not significant (p= 0.26), while the difference in IGF-BP3 between the two groups was statistically significant (p= 0.004). The performance of serum IGF-1 and IGF-BP3 as a diagnostic tool, expressed as AUC by ROC analyses, was quite low.

CONCLUSION

Neither IGF-I nor IGF-BP3 are an adequate substitute for the stimulus test in the diagnosis of growth hormone deficiency among children of short stature.

摘要

背景

生长激素缺乏症(GHD)的诊断基于临床和体格学特征,并结合生长激素激发试验的结果。

目的

评估血清胰岛素样生长因子-1(IGF-I)和胰岛素样生长因子结合蛋白3(IGF-BP3)水平在矮小儿童生长激素缺乏症诊断中的作用。

对象/方法:我们招募了207名青春期前矮小儿童,并将他们分为两组。一组由70名儿童(平均年龄7.93±2.35标准差)组成,这70名儿童在两项激发试验中的生长激素(GH)反应≤8 ng/ml,而另一组包含137名儿童(平均年龄7.92±2.11标准差),其生长激素峰值>8 ng/ml。测定两组儿童的血清IGF-1和IGF-BP3水平。

结果

两组之间血清IGF-I的差异不显著(p = 0.26),而两组之间IGF-BP3的差异具有统计学意义(p = 0.004)。血清IGF-1和IGF-BP3作为诊断工具的性能,通过ROC分析以曲线下面积(AUC)表示,相当低。

结论

在矮小儿童生长激素缺乏症的诊断中,IGF-I和IGF-BP3都不是刺激试验的合适替代方法。

相似文献

1
Are IGF-I and IGF-BP3 useful for diagnosing growth hormone deficiency in children of short stature?胰岛素样生长因子-I(IGF-I)和胰岛素样生长因子结合蛋白3(IGF-BP3)对诊断身材矮小儿童的生长激素缺乏症有用吗?
J Pediatr Endocrinol Metab. 2010 Dec;23(12):1273-9. doi: 10.1515/jpem.2010.201.
2
Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.胰岛素样生长因子-1及胰岛素样生长因子结合蛋白-3在矮小儿童生长激素缺乏症诊断中的评估
J Ayub Med Coll Abbottabad. 2009 Jul-Sep;21(3):40-5.
3
Does plasma IGF-BP3 measurement contribute to the diagnosis of growth hormone deficiency in children?血浆 IGF-BP3 测量对儿童生长激素缺乏症的诊断有帮助吗?
Ann Endocrinol (Paris). 2011 Jun;72(3):218-23. doi: 10.1016/j.ando.2011.01.002. Epub 2011 Jun 8.
4
Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.通过测量血清胰岛素样生长因子I和胰岛素样生长因子结合蛋白3水平预测矮小儿童生长激素激发试验的结果
J Pediatr. 1997 Feb;130(2):197-204. doi: 10.1016/s0022-3476(97)70343-3.
5
The role of insulin like growth factor (IGF)-1 and IGF-binding protein-3 in diagnosis of Growth Hormone Deficiency in short stature children.胰岛素样生长因子-1(IGF-1)和 IGF 结合蛋白-3 在身材矮小儿童生长激素缺乏症诊断中的作用。
Indian J Pediatr. 2009 Jul;76(7):699-703. doi: 10.1007/s12098-009-0115-0. Epub 2009 Apr 16.
6
Estrogen priming effect on growth hormone (GH) provocative test: a useful tool for the diagnosis of GH deficiency.雌激素对生长激素(GH)激发试验的启动效应:一种诊断生长激素缺乏症的有用工具。
J Clin Endocrinol Metab. 2000 Nov;85(11):4168-72. doi: 10.1210/jcem.85.11.6928.
7
[Usefulness of the measurement of insulin-like growth factor (IGF-I) and IGF-1 binding protein-3 (IGFBP-3) for the diagnosis of growth hormone (GH) deficiency in children].[胰岛素样生长因子(IGF-I)及IGF-1结合蛋白-3(IGFBP-3)测定在儿童生长激素(GH)缺乏症诊断中的应用价值]
Rev Med Chil. 1999 Jul;127(7):807-13.
8
Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.正常儿童和生长激素缺乏症儿童的血清游离胰岛素样生长因子I(IGF-I)、总IGF-I及IGF结合蛋白-3浓度
J Clin Endocrinol Metab. 1999 Jan;84(1):82-9. doi: 10.1210/jcem.84.1.5407.
9
Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.在对身材矮小儿童进行的前瞻性IGF-I生成试验期间血清IGF-I和IGFBP-3浓度的变化。
Clin Endocrinol (Oxf). 1998 Jun;48(6):719-24. doi: 10.1046/j.1365-2265.1998.00407.x.
10
Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency.
Horm Res. 1998 Sep;50(3):166-76. doi: 10.1159/000023268.

引用本文的文献

1
Insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency.胰岛素样生长因子-1 水平是生长激素缺乏症的诊断指标较差。
Sci Rep. 2021 Aug 9;11(1):16159. doi: 10.1038/s41598-021-95632-0.
2
Deficits in Bone Geometry in Growth Hormone-Deficient Prepubertal Boys Revealed by High-Resolution Peripheral Quantitative Computed Tomography.生长激素缺乏的青春期前男孩的骨几何结构缺陷:高分辨率外周定量计算机断层扫描研究。
Horm Res Paediatr. 2019;92(5):293-301. doi: 10.1159/000506229. Epub 2020 Mar 30.
3
Diagnostic value of serum IGF-1 and IGFBP-3 in growth hormone deficiency: a systematic review with meta-analysis.
血清胰岛素样生长因子-1和胰岛素样生长因子结合蛋白-3在生长激素缺乏症中的诊断价值:一项Meta分析的系统评价
Eur J Pediatr. 2015 Apr;174(4):419-27. doi: 10.1007/s00431-014-2406-3. Epub 2014 Sep 13.
4
Diagnosis of growth hormone deficiency in childhood.儿童生长激素缺乏症的诊断。
Curr Opin Endocrinol Diabetes Obes. 2012 Feb;19(1):47-52. doi: 10.1097/MED.0b013e32834ec952.